PROCEPT BioRobotics Corporation Net Income
PROCEPT BioRobotics Corporation (PRCT) reported Net Income of -$26.86 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement
us-gaap:NetIncomeLoss · last filed 2026-08-05
- PROCEPT BioRobotics Corporation net income (loss) attributable to parent for the quarter ending 2026-06-30 was -$26.86M.
- PROCEPT BioRobotics Corporation net income (loss) attributable to parent for the quarter ending 2026-03-31 was -$31.64M.
- PROCEPT BioRobotics Corporation net income (loss) attributable to parent for the quarter ending 2025-12-31 was $65.63M, a 9.43% decline year-over-year.
- PROCEPT BioRobotics Corporation net income (loss) attributable to parent for the quarter ending 2025-09-30 was -$21.41M.
- PROCEPT BioRobotics Corporation net income (loss) attributable to parent for fiscal 2020 was -$53.02M.
| Period end | Net Income (Loss) Attributable to Parent 3 month | Net Income (Loss) Attributable to Parent 6 month | Net Income (Loss) Attributable to Parent 9 month | Net Income (Loss) Attributable to Parent 12 month | Net Income (Loss) Attributable to Parent 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | -$26.86M 10-Q · filed 2026-08-05 | -$58.50M 10-Q · filed 2026-08-05 | $7.13M derived: sum of 3 quarters · filed 2026-08-05 | -$14.28M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2026-03-31 | -$31.64M 10-Q · filed 2026-08-05 | $33.99M derived: sum of 2 quarters · filed 2026-08-05 | $12.58M derived: sum of 3 quarters · filed 2026-08-05 | -$7.00M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-12-31 | $65.63M derived: DEF 14A 12 month − 10-Q 9 month · filed 2026-04-22 | $44.22M derived: sum of 2 quarters · filed 2026-04-22 | $24.64M derived: sum of 3 quarters · filed 2026-08-05 | -$95.57K DEF 14A · filed 2026-04-22 | -$95.57M 10-K · filed 2026-02-26 |
| 2025-09-30 | -$21.41M 10-Q · filed 2025-11-05 | -$40.99M derived: sum of 2 quarters · filed 2026-08-05 | -$65.73M 10-Q · filed 2025-11-05 | $6.74M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-06-30 | -$19.58M 10-Q · filed 2026-08-05 | -$44.32M 10-Q · filed 2026-08-05 | $28.15M derived: sum of 3 quarters · filed 2026-08-05 | $7.18M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-03-31 | -$24.74M 10-Q · filed 2026-08-05 | $47.73M derived: sum of 2 quarters · filed 2026-08-05 | $26.75M derived: sum of 3 quarters · filed 2026-08-05 | $1.13M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2024-12-31 | $72.47M derived: DEF 14A 12 month − 10-Q 9 month · filed 2026-04-22 | $51.49M derived: sum of 2 quarters · filed 2026-04-22 | $25.87M derived: sum of 3 quarters · filed 2026-04-22 | -$91.41K DEF 14A · filed 2026-04-22 | -$91.41M 10-K · filed 2025-02-27 |
| 2024-09-30 | -$20.97M 10-Q · filed 2025-11-05 | -$46.60M derived: sum of 2 quarters · filed 2025-11-05 | -$72.56M 10-Q · filed 2025-11-05 | $5.73M derived: sum of 4 quarters · filed 2026-04-22 | |
| 2024-06-30 | -$25.63M 10-Q · filed 2025-11-05 | -$51.58M 10-Q · filed 2025-08-07 | $26.70M derived: sum of 3 quarters · filed 2026-04-22 | $2.08M derived: sum of 4 quarters · filed 2026-04-22 | |
| 2024-03-31 | -$25.96M 10-Q · filed 2025-11-05 | $52.33M derived: sum of 2 quarters · filed 2026-04-22 | $27.71M derived: sum of 3 quarters · filed 2026-04-22 | $2.42M derived: sum of 4 quarters · filed 2026-04-22 | |
| 2023-12-31 | $78.29M derived: DEF 14A 12 month − 10-Q 9 month · filed 2026-04-22 | $53.67M derived: sum of 2 quarters · filed 2026-04-22 | $28.38M derived: sum of 3 quarters · filed 2026-04-22 | -$105.90K DEF 14A · filed 2026-04-22 | -$105.90M 10-K · filed 2024-02-28 |
| 2023-09-30 | -$24.62M 10-Q · filed 2024-10-28 | -$49.91M derived: sum of 2 quarters · filed 2024-10-28 | -$78.39M 10-Q · filed 2024-10-28 | -$19.50M derived: sum of 4 quarters · filed 2026-04-22 | |
| 2023-06-30 | -$25.29M 10-Q · filed 2024-10-28 | -$53.77M 10-Q · filed 2024-08-02 | $5.13M derived: sum of 3 quarters · filed 2026-04-22 | -$17.49M derived: sum of 4 quarters · filed 2026-04-22 | |
| 2023-03-31 | -$28.48M 10-Q · filed 2024-10-28 | $30.41M derived: sum of 2 quarters · filed 2026-04-22 | $7.80M derived: sum of 3 quarters · filed 2026-04-22 | -$11.39M derived: sum of 4 quarters · filed 2026-04-22 | |
| 2022-12-31 | $58.89M derived: DEF 14A 12 month − 10-Q 9 month · filed 2026-04-22 | $36.28M derived: sum of 2 quarters · filed 2026-04-22 | $17.10M derived: sum of 3 quarters · filed 2026-04-22 | -$87.15K DEF 14A · filed 2026-04-22 | -$87.15M 10-K · filed 2023-02-28 |
| 2022-09-30 | -$22.61M 10-Q · filed 2023-11-02 | -$41.80M derived: sum of 2 quarters · filed 2023-11-02 | -$58.98M 10-Q · filed 2023-11-02 | -$17.54M derived: sum of 4 quarters · filed 2026-04-22 | |
| 2022-06-30 | -$19.18M 10-Q · filed 2023-11-02 | -$36.37M 10-Q · filed 2023-07-28 | $5.08M derived: sum of 3 quarters · filed 2026-04-22 | -$9.03M derived: sum of 4 quarters · filed 2026-04-22 | |
| 2022-03-31 | -$17.18M 10-Q · filed 2023-11-02 | $24.26M derived: sum of 2 quarters · filed 2026-04-22 | $10.16M derived: sum of 3 quarters · filed 2026-04-22 | -$4.42M derived: sum of 4 quarters · filed 2026-04-22 | |
| 2021-12-31 | $41.45M derived: DEF 14A 12 month − 10-Q 9 month · filed 2026-04-22 | $27.34M derived: sum of 2 quarters · filed 2026-04-22 | $12.76M derived: sum of 3 quarters · filed 2026-04-22 | -$59.85K DEF 14A · filed 2026-04-22 | -$59.85M 10-K · filed 2022-03-22 |
| 2021-09-30 | -$14.10M 10-Q · filed 2022-11-04 | -$28.68M derived: sum of 2 quarters · filed 2022-11-04 | -$41.51M 10-Q · filed 2022-11-04 | -$56.78M derived: sum of 4 quarters · filed 2022-11-04 | |
| 2021-06-30 | -$14.58M 10-Q · filed 2022-11-04 | -$27.40M 10-Q · filed 2022-08-05 | -$42.68M derived: sum of 3 quarters · filed 2022-11-04 | -$54.69M derived: sum of 4 quarters · filed 2022-11-04 | |
| 2021-03-31 | -$12.82M 10-Q · filed 2022-11-04 | -$28.10M derived: sum of 2 quarters · filed 2022-11-04 | -$40.11M derived: sum of 3 quarters · filed 2022-11-04 | -$52.71M derived: sum of 4 quarters · filed 2022-11-04 | |
| 2020-12-31 | -$15.28M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22 | -$27.29M derived: sum of 2 quarters · filed 2022-03-22 | -$39.89M derived: sum of 3 quarters · filed 2022-03-22 | -$53.02M 10-K · filed 2022-03-22 | |
| 2020-09-30 | -$12.01M 10-Q · filed 2021-11-05 | -$24.61M derived: sum of 2 quarters · filed 2021-11-05 | -$37.74M 10-Q · filed 2021-11-05 | ||
| 2020-06-30 | -$12.61M 10-Q · filed 2021-11-05 | -$25.73M derived: sum of 2 quarters · filed 2021-11-05 | |||
| 2020-03-31 | -$13.13M 10-Q · filed 2021-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |